4,258
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Comment on: Devices and formulations for pulmonary vaccination

&
Pages 1593-1595 | Published online: 26 Aug 2013

Bibliography

  • Tonnis WF, Lexmond AJ, Frijlink HW, et al. Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv 2013; published online June 21, 2013; doi:10.1517/17425247.2013.810622
  • Kesser KC, Geller DE. New aerosol delivery devices for cystic fibrosis. Respir Care 2009;54:754-68
  • Hardaker LEA, Hatley RHM. In vitro characterization of the I-neb adaptive aerosol delivery (AAD) System. J Aerosol Med Pulm Drug Deliv 2010;23(Suppl 1):S11-20
  • Patil JS, Sarasija S. Pulmonary drug delivery strategies: a concise, systematic review. Lung India 2012;29:44-9
  • Maillet A, Congy-Jolivet N, Le Guellic S, et al. Aerodynamical, immunological and pharmacological properties of anticancer antibody cetuximab following nebulization. Pharm Res 2008;25:1318-26
  • Lau S, Diaz K, Smaldone G, Condos R. The effect of inhaled IFN-γ on the cytokine profile in the alveolar space in idiopathic pulmonary fibrosis (IPF). Chest 2011;140(4):928A
  • DeVincenzo JP, Cehelsky J, Foote K, et al. Early clinical evaluation of an RNA interference (RNAi) based therapy for respiratory syncytial virus (RSV) infection. Poster presented at: Pediatric Academic Societies Conference; 6 May 2007; Toronto, Canada
  • Geller DE, Kesser KE. The I-neb adaptive aerosol delivery system enhances delivery of A1-Antitrypsin with controlled inhalation. J Aerosol Med Pulm Drug Deliv 2010;23(Suppl 1):S55-S59
  • Tservistas M, Fuchs C. Principles of nebulizer technology. Inhalation. 2011. Available from: www.inhalationmag.com/Content/getArticle.aspx?ItemID=9cb040ba-2498-4df6-85dd-3c6f7e9517ef [Last accessed 5 July 2013]
  • Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir Care 2005;50:1161-76
  • Nikander K, Prince I, Coughlin S, et al. Mode of breathing – tidal or slow and deep – through the I-neb adaptive aerosol delivery (AAD) system affects lung deposition of 99mTc-DTPA. J Aerosol Med Pulm Drug Deliv 2010;23(Suppl 1):S37-44

Bibliography

  • Niven NW, Ip AY, Mittelman S, et al. Some factors associated with the ultrasonic nebulization of proteins. Pharm Res 1995;12:53-9
  • Khatri L, Taylor KM, Craig DQ, et al. An assessment of jet and ultrasonic nebulisers for the delivery of lactate dehydrogenase solutions. Int J Pharm 2001;227:121-31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.